Skip to content
NYSE · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · LARGE CAP

Teladoc Health, Inc. TDOC

13 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.5B
▼ 1.5% YoY
$-200.3M
$285.5M
▲ 0.9% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 2.5B
Revenue, FY2025 · full 13-year series below
Revenue $B Net income $B
FY2025 · Revenue 2.5 · Net income -0.2
1B2B-5B-10B
20132016201920222025
Compound annual growth
+1.7%
+18.3%
+41.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +18.3% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−8 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -10.4% · Net -7.9%
-200%-400%
201320192025
ROE
FY2025 · ROE -13.9%
-50%-100%
201320192025
Three returns, three denominators.

Each USD of equity lost 14 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 285.5
150.0M300.0M-25.0M-50.0M
201320192025
Net buybacks $ Dividends $
FY2014 · Dividends · · Net buybacks -379000.0
25000.050000.0-150000.0-300000.0
20132014

Total assetsUSD 2.9B
EquityUSD 1.4B
CashUSD 781.1M
Current ratio2.77×

Equity funds 48% of total assets.

The 13-year record

13 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
TDOC, 13-year financial record
Metric 2025202420232022202120202019201820172016201520142013
Revenue $B2.52.62.62.42.01.10.60.40.20.10.10.00.0
Operating income $B−0.3−1.0−0.2−13.7−0.3−0.5−0.1−0.1−0.1−0.1−0.1−0.0−0.0
EBITDA $B◌◌◌−13.4−0.1−0.4−0.0−0.0−0.1−0.1−0.1−0.0−0.0
Income tax $B−0.00.00.0−0.00.0−0.1−0.00.0−0.00.00.00.00.0
Net income $B−0.2−1.0−0.2−13.7−0.4−0.5−0.1−0.1−0.1−0.1−0.1−0.0−0.0
Free cash flow $B0.30.30.30.20.2−0.10.0−0.0−0.0−0.1−0.1−0.0−0.0
EPS, diluted $−1.14−5.87−1.34−84.60−2.73−5.36−1.38−1.47−1.93−1.75−2.91−10.25−8.05
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————————
ROE %−13.9−52.5−9.5−148.8−2.7−5.7−9.8−12.4−27.0−36.3———
Shares out B0.180.170.170.160.160.150.070.070.060.050.040.00◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 56 reconciliationsAUDITED

Reconciled in 13 of the 13 fiscal years we could check. 14 checks were skipped: the balance sheet is not tagged before 2014. Six checks were skipped: EPS is not tagged before 2013. Six checks were skipped: revenue is not tagged before 2013.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Offices & Clinics of Doctors of Medicine
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2013

Share this section

Download image